Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 3
2008 1
2011 6
2012 1
2013 7
2014 6
2015 8
2016 9
2017 7
2018 5
2019 6
2020 13
2021 9
2022 9
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA; International Neoadjuvant Melanoma Consortium members; Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV. Amaria RN, et al. Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8. Lancet Oncol. 2019. PMID: 31267972 Review.
Neoadjuvant Immunotherapy in Melanoma: The Paradigm Shift.
Hieken TJ, Kreidieh F, Aedo-Lopez V, Block MS, McArthur GA, Amaria RN. Hieken TJ, et al. Among authors: block ms. Am Soc Clin Oncol Educ Book. 2023 Jan;43:e390614. doi: 10.1200/EDBK_390614. Am Soc Clin Oncol Educ Book. 2023. PMID: 37116111 Free article.
Management of local or regional non-nodal disease.
Racz JM, Block MS, Baum CL, Jakub JW. Racz JM, et al. Among authors: block ms. J Surg Oncol. 2019 Jan;119(2):187-199. doi: 10.1002/jso.25330. Epub 2018 Dec 12. J Surg Oncol. 2019. PMID: 30548554 Review.
Merkel cell carcinoma of unknown primary: Clinical presentation and outcomes.
Broida SE, Chen XT, Baum CL, Brewer JD, Block MS, Jakub JW, Pockaj BA, Foote RL, Markovic SN, Hieken TJ, Houdek MT. Broida SE, et al. Among authors: block ms. J Surg Oncol. 2022 Nov;126(6):1080-1086. doi: 10.1002/jso.27010. Epub 2022 Jul 9. J Surg Oncol. 2022. PMID: 35809230 Review.
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer.
Lheureux S, Matei DE, Konstantinopoulos PA, Wang BX, Gadalla R, Block MS, Jewell A, Gaillard SL, McHale M, McCourt C, Temkin S, Girda E, Backes FJ, Werner TL, Duska L, Kehoe S, Colombo I, Wang L, Li X, Wildman R, Soleimani S, Lien S, Wright J, Pugh T, Ohashi PS, Brooks DG, Fleming GF. Lheureux S, et al. Among authors: block ms. J Immunother Cancer. 2022 Mar;10(3):e004233. doi: 10.1136/jitc-2021-004233. J Immunother Cancer. 2022. PMID: 35288469 Free PMC article. Clinical Trial.
The dynamic human immune response to cancer: it might just be rocket science.
Holtan SG, Dronca RS, Nevala WK, Porrata LF, Mansfield AS, Block MS, Leontovich AA, Grotz TE, Turner JD, Frisch HP, Markovic SN. Holtan SG, et al. Among authors: block ms. Immunotherapy. 2011 Sep;3(9):1021-4. doi: 10.2217/imt.11.109. Immunotherapy. 2011. PMID: 21913823 Free article. No abstract available.
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.
Luo Y, Shreeder B, Jenkins JW, Shi H, Lamichhane P, Zhou K, Bahr DA, Kurian S, Jones KA, Daum JI, Dutta N, Necela BM, Cannon MJ, Block MS, Knutson KL. Luo Y, et al. Among authors: block ms. J Immunother Cancer. 2023 Nov;11(11):e007661. doi: 10.1136/jitc-2023-007661. J Immunother Cancer. 2023. PMID: 37918918 Free PMC article.
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2.
Mudrick HE, Massey S, McGlinch EB, Parrett BJ, Hemsath JR, Barry ME, Rubin JD, Uzendu C, Hansen MJ, Erskine CL, Van Keulen VP, Drelich A, Panos JA, Fida M, Suh GA, Peikert T, Block MS, Tseng CK, Olivier GR, Barry MA. Mudrick HE, et al. Among authors: block ms. Sci Adv. 2022 Aug 26;8(34):eabm8563. doi: 10.1126/sciadv.abm8563. Epub 2022 Aug 24. Sci Adv. 2022. PMID: 36001674 Free PMC article.
94 results